1. Home
  2. NNNN vs PRA Comparison

NNNN vs PRA Comparison

Compare NNNN & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$33.50

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo ProAssurance Corporation

PRA

ProAssurance Corporation

HOLD

Current Price

$24.18

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
PRA
Founded
2021
1976
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
NNNN
PRA
Price
$33.50
$24.18
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$22.50
AVG Volume (30 Days)
37.4K
427.9K
Earning Date
04-28-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
0.66
Revenue
$6,920,153.00
$1,120,385,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.24
P/E Ratio
$554.67
$36.78
Revenue Growth
N/A
N/A
52 Week Low
$5.18
$13.90
52 Week High
$55.65
$24.41

Technical Indicators

Market Signals
Indicator
NNNN
PRA
Relative Strength Index (RSI) 49.21 56.87
Support Level $32.93 $24.03
Resistance Level $43.00 $24.24
Average True Range (ATR) 4.09 0.09
MACD 0.00 0.01
Stochastic Oscillator 33.23 73.91

Price Performance

Historical Comparison
NNNN
PRA

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Share on Social Networks: